Researchers at sarcomas research group at the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) have been tested in 19 patients a new therapeutic combinatio...
Read moreCientíficos del Centro Nacional de Investigaciones Cardiovasculares (CNIC) han descubierto una posible nueva vía de tratamiento para tres tipos de leucemia, al establecer que el microambiente que co...
Read moreColon cancer development starts with the formation of benign tumours called adenomas. It is estimated that between 30% and 50% of people over 50 will develop one of these tumours. These adenomas or po...
Read moreRoger Gomis’ team, in collaboration with another two groups in IRB Barcelona’s Oncology Programme, reveal in Nature Cell Biology the genes and mechanisms that allow liver metastasis to colonize th...
Read moreA study by IBEC researchers reveals in Nature Materials how mammary cells detect tissue stiffening, which is key to the development of breast cancer
Read moreEl objetivo es involucrar a mucha gente en una labor muy importante para la sociedad como es la investigación y hacerlo a través del deporte
Read moreRoche (SIX: RO, ROG; OTCQX: RHHBY) and Oryzon Genomics SA today announced they have entered into a worldwide collaboration to research, develop and commercialize inhibitors of Lysine Specific Demethyl...
Read more5-03-2014. Expertos internacionales analizan en el CIMA de la Universidad de Navarra los avances en investigación para mejorar los ensayos clínicos actuales Un centenar de expertos interna...
Read moreCon motivo del Día Mundial contra el Cáncer, el Grupo Zeltia –que cumplirá 75 años el próximo 3 de agosto- ha consolidado su compromiso con la innovación en la lucha contra esta enfermedad,...
Read morehe First Specific LSD1 Inhibitor to Enter the Clinic. Barcelona, Spain. January 16th, 2014. ORYZON, a biopharmaceutical company with a strong focus on epigenetics, hasannounced that has receiv...
Read moreResults presented include analyses of predictive biomarkers and novel mechanisms of resistance to targeted therapies, as well as the early results of whole exome and transcriptome sequencing in col...
Read more